← Evidence map

TrialInternational journal of clinical oncology2026

Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study).

Motoyuki Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study). | OpenQuestion